قارن الطرق
راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.
| فحص نفاذية خلايا كـاكـو-2× | معامل التشابه بالذوبان f1/f2× | |
|---|---|---|
| المجال | علم الأدوية | علم الأدوية |
| العائلة | Process / pipeline | Process / pipeline |
| سنة النشأة≠ | 1989 | 1996 |
| صاحب الطريقة≠ | Ingrid Hidalgo | James Moore and Hector Flanner |
| النوع≠ | absorption screening | similarity testing |
| المصدر التأسيسي≠ | Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗ | Moore, J. W., & Flanner, H. H. (1996). Mathematical comparison of dissolution profiles. Pharmaceutical Technology, 20(6), 64-74. link ↗ |
| الأسماء البديلة | Caco-2 assay, intestinal permeability, ADME screening | f1, f2, similarity factor |
| ذات صلة | 3 | 3 |
| الملخص≠ | The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport. | The f1 and f2 factors are dimensionless statistical measures developed by Moore and Flanner to quantify the similarity between two dissolution profiles. Adopted by regulatory agencies (FDA, EMA) as the gold standard for comparing dissolution curves, these factors enable rapid assessment of whether formulation changes significantly impact drug release. |
| ScholarGateمجموعة البيانات ↗ |
|
|